Viewing Study NCT05395533


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2025-12-31 @ 11:47 PM
Study NCT ID: NCT05395533
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-25
First Post: 2022-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
Sponsor: Zhejiang Teruisi Pharmaceutical Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module